12:20 p.m. ET Late Tuesday, Eli Lilly CEO David Ricks took to the stage at the J.P. Morgan Healthcare Conference to explain his views of the booming GLP-1 space. Earlier in the day, Lilly warned ...

Eli Lilly forecasts $45 billion in 2024 revenue, a 32% growth but $400 million below Q3 guidance. Mounjaro and Zepbound expected to contribute $3.5 billion and $1.9 billion, respectively, to 2024 ...

Eli Lilly CEO David Ricks joins 'Squawk on the Street' to discuss the company's drug pipeline, 2025 outlook, state of the weight loss drugs market, status of the weight loss drug pill, revised ...

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration, including on issues around ...

This highlights the important research significance of cell therapy in the field of scleroderma. Figure 1. Illustration of Application of CAR-T Therapy treatment. Mesenchymal stem cells can be derived ...

In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be ...

A year after starting treatment for bladder cancer, Norfolk farmer DAVID JONES has spoken about his journey through chemotherapy and major surgery - which he hopes can bring positivity for other ...

Buried in the news from last month was an interesting nugget posted by Fierce Pharma: “Following a dinner at Trump’s Mar-a-Lago estate last week, Eli Lilly CEO David Ricks pointed to raising ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes. California Institute for Regenerative Medicine, Neurona Therapeutics, Vertex ...

David Chung is taking on Northwell ... of the Adult Bone Marrow Transplant and Cellular Therapy Services, and was also director of Adult Stem Cell Transplantation and Cancer Immunotherapy Fellowships.